Answer
Hemgenix (etranacogene dezaparvovec) is contraindicated in hypersensitivity to the active substance or any excipient, active infections that are acute or uncontrolled chronic, and known advanced hepatic fibrosis or cirrhosis.
Sources for this answer
- HemgenixCSL Behring UK Limited · emc · SmPC §4.3 Contraindications · Version 8Document updated
Sources checked